To assess key global surgical indicators, including postoperative mortality.
To determine the optimal timing of surgery following SARS-CoV-2 infection. All patients are eligible to be included regardless of their SARS-CoV-2 status, so all hospitals can get involved even if they have not had any SARS-CoV-2 patients.
Key points about GlobalSurg-CovidSurg Week:
Prospective, observational cohort study, with no changes to patient management.
All hospitals can participate
All surgical specialties can participate
Data collection will be in 7-day blocks in October 2020.
All collaborators will be included as PubMed citable co-authors on resulting publications.
We would greatly value your collaboration with this study. If you are interested, here are the steps to get involved:
Please register your interest on our online form at is.gd/surgweek.
Access the study documents online at globalsurg.org/surgweek. The protocol has been translated to Arabic, Chinese, French, German (coming soon), Italian, Macedonian, Portugese / Brazilian, Russian (coming soon), and Spanish.
For GlobalSurg-CovidSurg Week we are aiming to have as broad and globally representative a mix of hospitals as possible. Please consider reaching out to colleagues in nearby district or rural hospitals to invite them to participate in the study.
We think this will be the largest surgical study ever, as already 1200 hospitals across 108 countries have expressed an interest in participating! We would love to work with you as part of this exciting collaboration!